Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2003
08/14/2003US20030153544 Fatty acid derivatives
08/14/2003US20030153542 Novel anti-inflammatory androstane derivative compositions
08/14/2003US20030153539 Use of estramustine phosphate or a metabolite thereof in preparation of anticarcinogenic agent
08/14/2003US20030153531 Modified polysaccharides exhibiting altered biological recognition
08/14/2003US20030153530 Solubility enhancing component other than a cyclodextrin, particularly a polyanionic component, an oxy-chloro component to aid in preserving the composition, liquid carrier
08/14/2003US20030153529 Dextrin containing compositions for prevention of adhesions
08/14/2003US20030153526 Compositions contain antisense oligonucleotides that hybridize to Grb2 and Crkl nucleic acids, gene products of which are known to interact with tumorigenic protein bcr-abl
08/14/2003US20030153521 Nucleic acid treatment of diseases or conditions related to levels of Ras
08/14/2003US20030153491 Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
08/14/2003US20030153490 Insulin conjugates and methods of use thereof
08/14/2003US20030153096 For reference standards in immunoassays; drug screening
08/14/2003US20030153081 Viral core protein-cationic lipid-nucleic acid-delivery complexes
08/14/2003US20030153046 Interferon gamma conjugates
08/14/2003US20030153016 PSCA: prostate stem cell antigen
08/14/2003US20030152651 Herbal composition for angina pectoris, method to prepare same and uses thereof
08/14/2003US20030152650 Pharmaceutical composition for prevention and treatment of premature ejaculation and/or hypersensitivity of sexual stimulation
08/14/2003US20030152642 Mixture of chondroitin sulfate, glucosamine and hyaluronic acid
08/14/2003US20030152638 Injectable opioid partial agonist or opioid antagonist microparticle compositions and their use in reducing consumption of abused substances
08/14/2003US20030152637 Administering by injection; glycolic acid-lactic acid copolymer; sustained release particles
08/14/2003US20030152635 Lipid nanocapsules, preparation process and use as medicine
08/14/2003US20030152631 Aseptics
08/14/2003US20030152627 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
08/14/2003US20030152626 Substance P antagonist; antidepressants; central nervous system disorders; respiratory system disorders
08/14/2003US20030152623 Sustained release; immobilization
08/14/2003US20030152618 Immobilized unto polyoxyethylene glycol
08/14/2003US20030152617 Capsule, tablet with enteric, protective coatings; bioavailability
08/14/2003US20030152616 Rosin ester as crystal growth inhibitor
08/14/2003US20030152615 Enhanced drug delivery in transdermal systems
08/14/2003US20030152614 Enhanced drug delivery in transdermal systems
08/14/2003US20030152613 Steroid on carrier containing pressure sensitive adhesive
08/14/2003US20030152612 Multilayer flexible patch; transdermal skin therapy
08/14/2003US20030152611 Pharmaceutical compositions for transdermal administration of anti-inflammatory agents
08/14/2003US20030152602 Topical applying; tissue penetration; bioavailability
08/14/2003US20030152595 Storage stability
08/14/2003US20030152585 Herbal formulation
08/14/2003US20030152578 Tumor homing molecules, conjugates derived therefrom, and methods of using same
08/14/2003US20030152553 Transfection, transduction of cells
08/14/2003US20030152548 Crosslinked polyester; enhanced cell adhesion
08/14/2003US20030152547 Three-dimensional networks; biocompatibility
08/14/2003US20030152531 Multifunctional particulate additive for personal care and cosmetic compositions, and the process of making the same
08/14/2003US20030152522 System for delivering antiadhesion composition comprising canister containing composition, valve adapted to permit flow of antiadhesion composition therethrough, pressure source; surgery
08/14/2003US20030152521 Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient
08/14/2003US20030152514 Methods for using anti-MUC18 antibodies
08/14/2003CA2485064A1 Albumin-fused kunitz domain peptides
08/14/2003CA2476218A1 Therapeutic compounds
08/14/2003CA2475539A1 Hiv inhibiting proteins
08/14/2003CA2475493A1 Inclusion complexes of semicarbazones into cyclodetrins and uses thereof
08/14/2003CA2475382A1 Albumin-fused anti-angiogenesis peptides
08/14/2003CA2475247A1 Anti-pathogen treatments
08/14/2003CA2475211A1 Lyophilised preparation comprising immunocytokines
08/14/2003CA2475209A1 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
08/14/2003CA2475187A1 Therapeutic polyesters and polyamides
08/14/2003CA2475071A1 Stabilization of protein preparations
08/14/2003CA2474921A1 Pharmaceutical tablet
08/14/2003CA2474919A1 Formulation comprising bioactive agents and method of using same
08/14/2003CA2474398A1 New immunoeffector compounds
08/14/2003CA2474283A1 Amino acid sequences capable of facilitating penetration across a biological barrier
08/14/2003CA2474190A1 Pharmaceutical dosage form for mucosal delivery
08/14/2003CA2473802A1 Engineering absorption of therapeutic compounds via colonic transporters
08/14/2003CA2473212A1 Pharmaceutical composition which improves in vivo gene transfer
08/14/2003CA2473143A1 Compositions containing oat straw and willowherb extract
08/14/2003CA2472265A1 Immunogenic formulations of variable peptidic epitopes and process for preparation thereof
08/14/2003CA2472249A1 Pharmaceutical compositions for hepatitis c viral protease inhibitors
08/14/2003CA2469748A1 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin
08/14/2003CA2455881A1 A stable pharmaceutical formulation comprising torsemide modification ii
08/14/2003CA2451650A1 Ligands to enhance cellular uptake of biomolecules
08/13/2003EP1334984A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
08/13/2003EP1334983A2 Inhibitory, monoclonal antibody against the protease which activates clotting factor VII
08/13/2003EP1334732A1 Pharmaceutical preparation containing copolyvidone
08/13/2003EP1334727A2 Method for obtaining antigenic structures enhancing specific cross reactivity
08/13/2003EP1334724A1 Compositions for external preparations
08/13/2003EP1334718A1 Drug composition comprising dipeptydyl aldehyde derivative
08/13/2003EP1334717A2 Pharmaceutical Compositions For Oral And Topical Administration
08/13/2003EP1334194A2 Imaging, diagnosis and treatment of disease
08/13/2003EP1334128A2 New multimeric interferon beta polypeptides
08/13/2003EP1334127A1 Single-chain multimeric polypeptides
08/13/2003EP1334117A1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements
08/13/2003EP1334114A2 Transcobalamin binding conjugates useful for treating abnormal cellular proliferation
08/13/2003EP1334091A2 Thioflavin derivatives and their use in diagnosis and therapy of alzheimer's disease
08/13/2003EP1333865A1 Inorganic low density radionuclide coated particles
08/13/2003EP1333864A1 Low density radionuclide-containing particulate material
08/13/2003EP1333851A1 Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities
08/13/2003EP1333850A2 Method and composition for inhibition of tumor growth and enhancing an immune response
08/13/2003EP1333844A2 Pharmaceutical preparation for the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma
08/13/2003EP1333830A2 Novel medicament compositions based on anticholinergics and corticosteroids
08/13/2003EP1333819A2 Inhalative solution formulation containing a tiotropium salt
08/13/2003EP1333818A2 Titratable dosage transdermal delivery system
08/13/2003EP1333816A2 Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same
08/13/2003EP1333815A1 Process for producing microparticles
08/13/2003EP1333814A1 Parenterally administrable microparticles
08/13/2003EP1333812A1 Microgranules based on active principle and method for making same
08/13/2003EP1333811A1 Liposomal formulation of mitoxantrone
08/13/2003EP1333810A2 Oral dosage self-emulsifying formulations of pyranone protease inhibitors
08/13/2003EP1333808A2 Electroprocessed composition used in drug delivery and cell encapsulation
08/13/2003EP1333807A2 Extended release erythromycin derivatives
08/13/2003EP1256340B1 Improved transdermal therapeutic system for the treatment of Parkinson's disease
08/13/2003EP1220656B1 Shaped body comprising an amphiphilic outer phase and a lipophilic inner phase
08/13/2003EP1163008B1 Use of trehalose for stabilising a liquid vaccine
08/13/2003EP1148793B1 Method of preparing microparticles of phytosterols or phytostanols
08/13/2003EP1098665B9 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
1 ... 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 ... 1712